V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029260 | 20157207 | 1.76 | 85.9 | Adjuvant (A) | 2021-09-20 | 2021-09-20 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100332183 |
| 20029304 | 20157208 | 1.75 | 70 | Adjuvant (A) | 2017-05-29 | 2017-06-14 | null | 02 | N | CAPECITABINE + CISPLATIN + RT | 100728754 |
| 20029348 | 20157209 | 1.81 | 59 | null | 2020-10-22 | 2020-10-22 | null | 2 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101614561 |
| 20029374 | 20157210 | 1.68 | 51.9 | null | 2017-10-20 | 2017-10-21 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100567196 |
| 20029441 | 20157211 | 1.63 | 77.8 | Curative (C) | 2019-08-22 | 2019-09-13 | Everolimus 10mg | N | Y | EVEROLIMUS | 101808794 |
| 20029579 | 20157212 | 1.76 | 52.6 | null | 2018-04-09 | 2018-04-27 | EVEROLIMUS | 02 | null | EVEROLIMUS | 100831972 |
| 20029616 | 20157213 | 1.58 | 74.1 | Palliative (P) | 2019-10-11 | 2019-10-13 | null | 02 | N | OXALIPLATIN | 101317396 |
| 20029720 | 20157214 | 1.68 | null | null | 2018-02-23 | 2018-02-24 | null | 02 | null | ENZALUTAMIDE | 101511925 |
| 20029737 | 20157215 | 1.7 | 89 | null | 2016-06-24 | 2016-08-29 | null | 02 | null | BEVACIZUMAB | 101547489 |
| 20029793 | 20157216 | 1.88 | 79.2 | null | 2020-09-24 | 2020-10-02 | null | 02 | null | CISPLATIN | 100755939 |
| 20029794 | 20157217 | 1.8 | 50 | null | 2016-08-16 | 2016-09-02 | null | 02 | null | CISPLATIN + ETOPOSIDE | 100507930 |
| 20029802 | 20157218 | 1.81 | 80 | 02 | 2018-11-05 | 2018-11-21 | null | 02 | N | NOT MATCHED | 101807115 |
| 20029913 | 20157219 | 1.65 | 44.5 | Curative (C) | 2019-02-26 | 2019-06-26 | null | N | N | EVEROLIMUS | 101471288 |
| 20030048 | 20157221 | 1.75 | 61 | Palliative (P) | 2016-12-19 | 2016-12-23 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 100146920 |
| 20030124 | 20157222 | 1.64 | 89 | Palliative (P) | 2018-03-22 | 2018-03-30 | null | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101223043 |
| 20030177 | 20157223 | 1.73 | 69.8 | Palliative (P) | null | 2019-01-24 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101322671 |
| 20030427 | 20157225 | 1.69 | 71.75 | null | 2016-11-05 | 2016-11-06 | null | 02 | null | CETUXIMAB + ENCORAFENIB | 100460397 |
| 20030452 | 20157226 | 1.68 | 75 | null | 2016-03-24 | 2016-03-31 | null | 02 | null | PEMBROLIZUMAB | 101210463 |
| 20030480 | 20157227 | 1.57 | 83.4 | null | null | 2018-04-15 | null | N | null | CISPLATIN + ETOPOSIDE | 100324300 |
| 20030713 | 20157228 | 1.74 | 67.35 | Palliative (P) | 2017-11-18 | 2017-12-02 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101581911 |
| 20030944 | 20157229 | 1.77 | 65.5 | null | 2016-06-28 | 2016-08-16 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100024182 |
| 20030999 | 20157230 | 1.7 | null | null | 2016-08-20 | 2016-08-26 | null | 02 | null | ENZALUTAMIDE | 100846103 |
| 20031032 | 20157231 | 1.75 | 89 | Palliative (P) | 2020-02-08 | 2020-03-23 | null | 02 | N | EVEROLIMUS | 100832197 |
| 20031086 | 20157232 | 1.7 | 71.8 | null | 2018-12-11 | 2019-01-01 | null | 02 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100715511 |
| 20031129 | 20157233 | 1.52 | 73.4 | Palliative (P) | null | 2016-05-07 | null | 02 | N | NOT MATCHED | 101493793 |
| 20031149 | 20157234 | 1.76 | 42.9 | null | 2015-04-09 | 2015-04-15 | null | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101816221 |
| 20031175 | 20157235 | 162.5 | 64.1 | Neo-adjuvant (N) | 2018-08-02 | 2018-08-02 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101670634 |
| 20031201 | 20157237 | 1.65 | 0 | Palliative (P) | 2020-03-29 | 2020-04-15 | null | 02 | null | OCTREOTIDE | 100863768 |
| 20031268 | 20157238 | 1.69 | 73.6 | null | 2019-04-05 | 2019-04-05 | null | 02 | null | ENZALUTAMIDE | 100294143 |
| 20031510 | 20157240 | 1.65 | 70.3 | Palliative (P) | 2017-12-30 | 2018-01-27 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100386721 |
| 20031514 | 20157241 | 1.83 | null | null | 2015-08-07 | 2015-08-13 | null | 02 | null | OXALIPLATIN | 101299547 |
| 20031545 | 20157242 | 1.56 | 54.75 | Palliative (P) | 2018-03-12 | 2018-03-12 | null | 2 | N | MITOMYCIN INTRAVESICULAR | 100425276 |
| 20031683 | 20157243 | 1.65 | 65.7 | null | 2016-09-23 | 2016-09-25 | EVEROLIMUS | 02 | N | EVEROLIMUS | 101546661 |
| 20031763 | 20157244 | 1.8 | 59.5 | null | 2018-12-08 | 2019-01-03 | null | 02 | null | TRIFLURIDINE + TIPIRACIL | 101259930 |
| 20032098 | 20157245 | 1.56 | null | null | 2016-08-31 | 2016-09-05 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100651562 |
| 20032135 | 20157246 | 1.77 | 99 | Palliative (P) | 2019-01-23 | 2019-01-28 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100683417 |
| 20032245 | 20157247 | 1.58 | 0 | Adjuvant (A) | 2020-10-15 | 2020-10-22 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101459748 |
| 20032339 | 20157248 | 1.69 | 72.4 | Neo-adjuvant (N) | null | 2020-01-13 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100656148 |
| 20032585 | 20157249 | 1.61 | 85 | Palliative (P) | 2021-10-14 | 2021-10-31 | null | 2 | N | SCALOP-2 TRIAL | 100231228 |
| 20032626 | 20157250 | 1.73 | 0 | null | 2017-12-09 | 2017-12-09 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101198710 |
| 20032642 | 20157251 | 1.69 | 86.4 | null | 2021-11-01 | 2022-04-07 | LUTETIUM-177 | 02 | null | OXALIPLATIN | 100478003 |
| 20032711 | 20157252 | 0 | 64.4 | null | 2020-01-27 | 2020-01-31 | null | 02 | null | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101242406 |
| 20032721 | 20157253 | 1.61 | 76.1 | null | 2018-02-05 | 2018-11-16 | LUTETIUM-177 | 2 | null | CARBOPLATIN + PACLITAXEL + RT | 101242849 |
| 20032865 | 20157254 | 1.61 | 59.8 | null | 2019-10-22 | 2019-12-02 | null | 02 | N | CISPLATIN | 100963668 |
| 20032923 | 20157256 | 1.68 | 40 | null | null | 2019-04-19 | null | N | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101446307 |
| 20033069 | 20157257 | 1.63 | 94.6 | Adjuvant (A) | null | 2016-04-10 | LUTETIUM-177 | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 100068110 |
| 20033126 | 20157258 | 1.73 | 81.6 | Adjuvant (A) | 2019-12-08 | 2019-12-29 | null | 02 | Y | PEMBROLIZUMAB | 100325987 |
| 20033173 | 20157259 | 1.8 | 50.7 | Palliative (P) | 2021-06-24 | 2021-06-24 | null | 02 | N | CISPLATIN + ETOPOSIDE | 101424088 |
| 20033511 | 20157261 | 1.57 | null | null | 2017-08-15 | 2017-08-29 | null | 02 | null | ENZALUTAMIDE | 100408179 |
| 20033590 | 20157262 | 1.65 | 40.6 | Adjuvant (A) | 2020-01-08 | 2020-01-12 | null | 02 | N | SCALOP-2 TRIAL | 101289267 |